Business Description
Pfizer Ltd
ISIN : INE182A01018
Share Class Description:
BOM:500680: Shs DematerialisedTotal Employee Number:
1,598Compare
Compare
Traded in other countries / regions
PFIZER.India IPO Date
1991-01-03Description
Pfizer Ltd is engaged in the manufacturing, marketing, distribution, and trading of pharmaceutical products. The Company operates through the Pharmaceuticals segment. Its business categories include Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. The Company sells its products mainly in India through independent distributors and derives maximum revenue from the domestic market.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 43.98 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 89.28 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 20.28 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.3 | |||||
3-Year EBITDA Growth Rate | 3.4 | |||||
3-Year EPS without NRI Growth Rate | 8.9 | |||||
3-Year FCF Growth Rate | 48 | |||||
3-Year Book Growth Rate | 9.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.86 | |||||
9-Day RSI | 51.42 | |||||
14-Day RSI | 51.74 | |||||
3-1 Month Momentum % | -4.81 | |||||
6-1 Month Momentum % | -1.93 | |||||
12-1 Month Momentum % | -14.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.06 | |||||
Quick Ratio | 5.31 | |||||
Cash Ratio | 4.92 | |||||
Days Inventory | 199.37 | |||||
Days Sales Outstanding | 29.88 | |||||
Days Payable | 80.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.62 | |||||
Dividend Payout Ratio | 0.21 | |||||
3-Year Dividend Growth Rate | -18.6 | |||||
Forward Dividend Yield % | 1.62 | |||||
5-Year Yield-on-Cost % | 3.88 | |||||
Shareholder Yield % | 1.67 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.9 | |||||
Operating Margin % | 33.59 | |||||
Net Margin % | 28.67 | |||||
EBITDA Margin % | 41.39 | |||||
FCF Margin % | 37.4 | |||||
OCF Margin % | 38.4 | |||||
ROE % | 17.67 | |||||
ROA % | 15.01 | |||||
ROIC % | 41.48 | |||||
3-Year ROIIC % | -22.51 | |||||
ROC (Joel Greenblatt) % | 300.65 | |||||
ROCE % | 23.46 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.28 | |||||
Forward PE Ratio | 25.73 | |||||
PE Ratio without NRI | 27.88 | |||||
Shiller PE Ratio | 32.42 | |||||
Price-to-Owner-Earnings | 26.63 | |||||
PEG Ratio | 5.26 | |||||
PS Ratio | 8.39 | |||||
PB Ratio | 5.03 | |||||
Price-to-Tangible-Book | 5.78 | |||||
Price-to-Free-Cash-Flow | 22.45 | |||||
Price-to-Operating-Cash-Flow | 21.86 | |||||
EV-to-EBIT | 18.41 | |||||
EV-to-EBITDA | 17.39 | |||||
EV-to-Revenue | 7.2 | |||||
EV-to-FCF | 19.24 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 2.62 | |||||
Price-to-DCF (Earnings Based) | 2.19 | |||||
Price-to-DCF (FCF Based) | 1.64 | |||||
Price-to-Median-PS-Value | 1.04 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.47 | |||||
Price-to-Graham-Number | 2.68 | |||||
| Price-to-Net-Current-Asset-Value | 6.86 | |||||
| Price-to-Net-Cash | 8.93 | |||||
Earnings Yield (Greenblatt) % | 5.43 | |||||
FCF Yield % | 4.46 | |||||
Forward Rate of Return (Yacktman) % | 7.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pfizer Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 25,196.5 | ||
| EPS (TTM) (₹) | 157.92 | ||
| Beta | 0.7987 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.16 | ||
| Volatility % | 18.21 | ||
| 14-Day RSI | 51.74 | ||
| 14-Day ATR (₹) | 100.285218 | ||
| 20-Day SMA (₹) | 4587 | ||
| 12-1 Month Momentum % | -14.8 | ||
| 52-Week Range (₹) | 4361 - 5878.55 | ||
| Shares Outstanding (Mil) | 45.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pfizer Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pfizer Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 75.000000 Cash Dividend | 2026-07-17 | 4,692.40 (-0.69%) | ||
| INR 130.000000 Cash Dividend | 2025-07-09 | 5,851.30 (-0.23%) | ||
| INR 35.000000 Cash Dividend | 2025-07-09 | 5,851.30 (-0.23%) | ||
| INR 35.000000 Cash Dividend | 2024-08-21 | 5,898.15 (+1.50%) | ||
| 2:1 Stock Split | 2000-06-12 | 501.58 (-0.68%) |
Show
Entries
Pfizer Ltd Frequently Asked Questions
What is Pfizer Ltd(BOM:500680)'s stock price today?
The current price of BOM:500680 is ₹4617.70. The 52 week high of BOM:500680 is ₹5878.55 and 52 week low is ₹4361.00.
When is next earnings date of Pfizer Ltd(BOM:500680)?
The next earnings date of Pfizer Ltd(BOM:500680) is .
Does Pfizer Ltd(BOM:500680) pay dividends? If so, how much?
The Dividend Yield %  of Pfizer Ltd(BOM:500680) is 1.62% (As of Today), Highest Dividend Payout Ratio of Pfizer Ltd(BOM:500680) was 0.51. The lowest was 0.09. And the median was 0.22. The  Forward Dividend Yield % of Pfizer Ltd(BOM:500680) is 1.62%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Pfizer Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers